Loading…
The Baldwin Insurance Group, Inc.
NASDAQ: BWIN Financials Insurance 🔎 Screen
🏹 Trader: ⭐ All Three 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High 📊 High Volume | BRS 100 Elite View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$2.0B
Market Cap
P/E
0.67
PEG
6.9%
ROCE
-5.2%
ROE
1.62
D/E
5.7%
OPM
0.0%
% from 52W High
92
α RS
🔍 BWIN is showing a momentum setup because RS Rating is 92 (top decile vs market), an ECS of 53.2 last quarter, and it's within 0% of its 52-week high. Net: Broad signal stack, not a recommendation. ? RS Rating ECS 52W High
Sources
RS Rating 92 · ECS 53.2 · 0% from 52W high
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for BWIN including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

The Baldwin Insurance Group, Inc. operates as an independent insurance distribution firm that delivers insurance and risk management solutions in the United States. The company operates through three segments: Insurance Advisory Solutions; Underwriting, Capacity & Technology Solutions; and Mainstreet Insurance Solutions. Its Insurance Advisory Solutions segment provides private risk management, commercial risk management, employee benefits, and Medicare insurance solutions for businesses and high-net-worth individuals, as well as their families. The Underwriting, Capacity & Technology Solutions segment offers MGA platform, that manufactures technology-enabled insurance product suite comprises personal, commercial, and professional lines. Its Mainstreet Insurance Solutions segment provides personal insurance, commercial insurance, and life and health solutions to individuals and businesses in communities, as well as offers reinsurance brokerage; and consultation for government assistance programs and solutions, including traditional Medicare and Medicare advantage and affordable care act to seniors and eligible individuals through a network of primarily independent contractor agents. The company was formerly known as BRP Group, Inc. and changed its name to The Baldwin Insurance Group, Inc. in May 2024. The Baldwin Insurance Group, Inc. was founded in 2011 and is headquartered in Tampa, Florida.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding BWIN
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 447.0K $9.8M 0.01% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Baldwin Q1 2026: Revenue $532M, Adj EBITDA $137M, 2% organic growth, CAC integration ahead by plan.
Revenue & Profitability
For Q1 2026, Baldwin reported total revenue of $532.2 million, GAAP net loss of $1.9 million, adjusted EBITDA of $137.2 million, and adjusted diluted EPS of $0.63. Organic revenue growth was 2% overall, or 5% after adjusting for transitory items. The company provided Q2 2026 guidance of revenue between $485-$495 million, adjusted EBITDA of $113-$118 million, and adjusted diluted EPS of $0.44-$0.48.
Outlook
Management sees a deeply soft property market with rate declines of 30-40% on coastal placements, expecting a rate/exposure headwind of 400-500 bps in Q2 and 100-200 bps for the full year. The Medicare marketplace disruption is expected to abate beginning next quarter. Overall, the company expects organic growth to accelerate ratably through the year, with high single-digit UCTS growth in Q2 and a return to teens in the back half.
Growth Drivers
Key growth drivers include the CAC partnership (27% revenue growth in Q1, 61% sales velocity), Juniper Re (over 90% growth), and the embedded mortgage business (Fairway Independent went live in April). The multifamily business grew 10% in the quarter. Baldwin expects organic growth to inflect in the back half of 2026 as headwinds are lapped and cross-sell opportunities from CAC mature.
Balance Sheet & CapEx
Capital expenditure specifics were not discussed on this call. However, the company is investing in AI capabilities, including a proprietary orchestration layer and an expanded partnership with Anthropic's Claude. The 3B30 Catalyst program is on track to deliver $3-$5 million in year savings, and $34 million of a $43 million cost synergy target from the CAC deal has already been actioned.
Margins
Adjusted EBITDA margin was 25.8% in Q1 2026, down 170 bps year-over-year due to the consolidation of CAC (different seasonality) and a large UCTS profit-sharing contract. Management expects margin expansion from the Catalyst program and the maturation of investments like embedded mortgage. The 3B30 program targets a 30% margin, and the combination of regular operating leverage and Catalyst is expected to achieve it.
Key Risks
Risks flagged include the soft property market (rate declines of 30-40%), the QBE builder book commission transition (lapped on May 1), Medicare marketplace disruption, and variability in transaction-related product lines at CAC. Leverage stood at 4.3x net debt to EBITDA, and management noted that M&A is difficult given the equity price. Analyst questions also highlighted the sustainability of growth from acquired businesses.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-30
Q2 2026 saw $493M in revenue, 37% adjusted EBITDA growth, and strong cash flow, with normalized organic growth at 8%. Integration of partnerships and AI initiatives are accelerating momentum, and guidance calls for mid-single-digit organic growth for the year.
Q1 2026 Q1 2026 2026-05-04
Q1 2026 saw $532M revenue, 2% organic growth (5% normalized), and strong synergy realization from new partnerships. Adjusted EBITDA rose 21% to $137M, with margin down due to mix. Guidance is unchanged, with organic growth expected to accelerate as headwinds subside.
Q4 2025 Q4 2025 2026-02-26
AI-driven disruption is reshaping insurance, but embedded distribution and proprietary products are driving resilient, high-margin growth. Despite Q4 headwinds, strong integration of recent acquisitions, margin expansion, and a robust 2026 outlook position the business for accelerated performance.
Q3 2025 Q3 2025 2025-11-04
Q3 saw 5% organic revenue growth and strong sales velocity, with Adjusted EBITDA flat year-over-year and margin contraction. Temporary headwinds from accounting changes and commission resets are expected to reverse in 2026, while the 3B/30 Catalyst program targets $40M in annualized savings by 2028.
Q2 2025 Q2 2025 2025-08-05
Q2 2025 saw 11% organic revenue growth, 14% adjusted EBITDA growth, and margin expansion, with strong new business and key acquisitions offsetting headwinds in builder commissions and Medicare. Full-year guidance was updated for high single-digit organic growth and $1.5–$1.52B revenue.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.